Trials / Completed
CompletedNCT00878540
Short-term Metabolic Effects of Mirtazapine in Healthy Subjects
Phase 1 Study of Mirtazapine in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Max-Planck-Institute of Psychiatry · Academic / Other
- Sex
- Male
- Age
- 20 Years – 25 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine metabolic changes upon a 7 day medication of 30 mg mirtazapine per day in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | mirtazapine | 30 mg mirtazapine once daily for 7 days |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2010-07-01
- Completion
- 2010-07-01
- First posted
- 2009-04-09
- Last updated
- 2010-09-16
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00878540. Inclusion in this directory is not an endorsement.